Healthcare Triangle, Inc. (Nasdaq: HCTI) Concludes \$3.6 Million Private Placement of Convertible Notes
Pleasanton, California, June 12, 2026 – Healthcare Triangle, Inc. (“HCTI” or the “Company”), a leader in digital transformation solutions for healthcare and life sciences, has announced the successful closing of a private placement offering. The Company issued 15% original issue discount senior convertible promissory notes with an aggregate principal amount of \$4.235 million, resulting in gross proceeds of approximately \$3.6 million before placement agent fees and other related offering expenses.
Key Details of the Private Placement
- Instrument: 15% original issue discount senior convertible promissory notes.
- Principal Amount: \$4.235 million.
- Gross Proceeds: Approximately \$3.6 million.
- Maturity: The notes mature on December 12, 2027.
- Conversion Feature: After six months from the original issue date, holders can convert the notes into HCTI common stock at a conversion price equal to 85% of the volume-weighted average price (VWAP) over the three trading days immediately preceding the conversion notice.
- Use of Proceeds: The Company intends to use net proceeds for repayment of certain prior indebtedness, potential strategic acquisitions, and general working capital purposes.
- Placement Agent: WallachBeth Capital LLC acted as the placement agent for the transaction.
- Regulatory Status: The notes and the underlying shares of common stock have not been registered under the Securities Act of 1933 or any state securities laws and may not be offered or sold in the United States without registration or an applicable exemption.
Potential Shareholder Impacts and Price-Sensitive Information
- Dilution Risk: The convertible notes may lead to equity dilution upon conversion, especially since the conversion price is set at a 15% discount to the prevailing VWAP. Investors should monitor future conversions, as they could increase the outstanding share count and potentially impact share price.
- Balance Sheet Strengthening: The transaction provides the Company with significant capital, which will be used to pay down prior debt, support potential strategic acquisitions, and bolster working capital. These actions could positively influence the Company’s growth prospects and financial stability.
- Strategic Flexibility: The capital raise strengthens HCTI’s ability to pursue strategic acquisitions, which could drive future growth and enhance shareholder value.
- Unregistered Securities: As the notes and shares are unregistered, liquidity of these securities may be limited, and trading by note holders may be subject to restrictions.
- Forward-Looking Statements: The Company has cautioned that forward-looking statements are subject to various risks and uncertainties, which can be reviewed in its latest SEC filings.
About Healthcare Triangle, Inc.
Based in Pleasanton, California, Healthcare Triangle specializes in digital transformation solutions for healthcare and life sciences organizations. The Company supports hospitals, health systems, payers, and pharma/life sciences companies in improving health outcomes through advanced data and information technology solutions. HCTI’s platforms, CloudEz™ and DataEz™, have achieved HITRUST risk-based, 2-year (r2) Certified status, demonstrating high standards for data protection and information security. Their expertise includes cloud, security and compliance, data lifecycle management, healthcare interoperability, and clinical & business performance optimization.
Forward-Looking Statements Disclaimer
This article contains forward-looking statements based on management’s current expectations, estimates, and projections. Actual results may differ materially due to risks and uncertainties. Investors should review Healthcare Triangle’s filings with the U.S. Securities and Exchange Commission, including the section titled “Risk Factors,” for further details. The Company assumes no obligation to update forward-looking statements except as required by law.
Disclaimer: This article is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any securities. Investors should conduct their own due diligence and consult with their financial advisors before making investment decisions. This article may contain forward-looking statements which are subject to risks and uncertainties. Please refer to official SEC filings for complete and up-to-date information.
